| Phase 3 |
| NCT06439563 |
Study to Evaluate the Efficacy and Safety of JP-1366 in the Prevention of NSAIDs-Induced… |
Peptic Ulcer |
Recruiting |
2024-11-01 |
| NCT07875933 |
Efficacy and Safety of JP-1366-based Triple Therapy in Helicobacter Pylori-positive… |
H. Pylori Eradication Therapy |
Not Yet Recruiting |
2026-10-15 |
| NCT07732075 |
Phase 3 Study of JP-1366: Efficacy and Safety of JP-1366 as Maintenance Therapy in… |
Maintenance of Healed Erosive Gastroesophageal Reflux Disease (ERD) |
Not Yet Recruiting |
2026-07-28 |
| NCT07160790 |
Phase 3 Study of JP-1366: Efficacy and Safety of JP-1366 in Patients With Non-erosive… |
Non-erosive Gastroesophageal Reflux Disease |
Not Yet Recruiting |
2025-09-08 |
| Phase 2 |
| NCT07370818 |
To Evaluate the Efficacy and Safety of JPI-547 in Combination With Bevacizumab as… |
Ovarian Cancer |
Not Yet Recruiting |
2026-01-27 |
| Phase 1/2 |
| NCT05257993 |
Study to Assess the Safety, Tolerability of JPI-547 in Combination With Modified… |
Pancreatic Ductal Adenocarcinoma |
Recruiting |
2026-04-13 |
| NCT07364422 |
To Evaluate the Safety and Tolerability of Study Drug as a Third-line and Beyond Therapy… |
Gastric Cancer (GC) |
Not Yet Recruiting |
2026-01-23 |
| Phase 1 |
| NCT07265466 |
to Evaluate the Safety and the Pharmacokinetic and Pharmacodynamic Interactions Between… |
Drug Drug Interaction (DDI) |
Recruiting |
2025-12-04 |
| NCT07570186 |
Food and Ethnicity Effects on Pharmacokinetics and Safety of JPI-547 in Healthy Male… |
Healthy Volunteers |
Not Yet Recruiting |
2026-05-06 |